MedPath

The altered gene expression profiles of leprosy causing bacteria and the human host in patients with chronic and recurrent type 2 lepra reaction.

Not Applicable
Conditions
Health Condition 1: A305- Lepromatous leprosy
Registration Number
CTRI/2023/07/054861
Lead Sponsor
Indian Association of Dermatologists, Venereologists & Leprologists (IADVL)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

All the cases of severe chronic and recurrent erythema nodosum leprosum, defined as ENLIST ENL Severity Scale (EESS) score =9, who will present to the OPD of the Dermatology department

Exclusion Criteria

i.Patients with known immunodeficiency or on immunosuppressive drugs within last month

ii.Patients not willing to give consent

iii.Pregnancy and lactation

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To characterize the transcriptome profiles of host-bacilli in patients with chronic & recurrent erythema nodosum leprosumTimepoint: April 2025
Secondary Outcome Measures
NameTimeMethod
To observe the association between antimicrobial resistance & the <br/ ><br>presence of chronic & recurrent erythema nodosum leprosumTimepoint: April 2025
© Copyright 2025. All Rights Reserved by MedPath